Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Calcifediol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 443,847Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New Clinical Data on OPKO Health™s RAYALDEE Presented at Kidney Week 2023
    New Clinical Data on OPKO Health™s RAYALDEE Presented at Kidney Week 2023

    02 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/02/2772514/0/en/New-Clinical-Data-on-OPKO-Health-s-RAYALDEE-ER-Calcifediol-Presented-at-Kidney-Week-2023.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share
    OPKO Health to Present New Clinical Data on Rayaldee at Kidney Week 2023
    OPKO Health to Present New Clinical Data on Rayaldee at Kidney Week 2023

    25 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/25/2766975/0/en/OPKO-Health-to-Present-New-Clinical-Data-on-Rayaldee-ER-Calcifediol-at-Kidney-Week-2023.html

    GLOBENEWSWIRE
    25 Oct 2023
    Share Share
    RAYALDEE Launched in Germany by OPKO Health’s Licensee, VFMCRP
    RAYALDEE Launched in Germany by OPKO Health’s Licensee, VFMCRP

    03 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/03/2378541/0/en/RAYALDEE-Launched-in-Germany-by-OPKO-Health-s-Licensee-VFMCRP.html

    GLOBENEWSWIRE
    03 Feb 2022
    Share Share
    OPKO Health Announces Topline Data from Phase 2 Trial of Rayaldee
    OPKO Health Announces Topline Data from Phase 2 Trial of Rayaldee

    24 Dec 2021

    // TRIALSITENEWS

    https://trialsitenews.com/opko-health-announces-topline-data-from-phase-2-trial-of-rayaldee-in-treating-mild-to-moderate-covid-19-supporting-the-use-of-vitamin-d-repletion-therapy/

    TRIALSITENEWS
    24 Dec 2021
    Share Share
    OPKO Health completes enrollment in phase 2 trial of Rayaldee to treat Covid-19
    OPKO Health completes enrollment in phase 2 trial of Rayaldee to treat Covid-19

    01 Sep 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=142236&sid=2

    PHARMABIZ
    01 Sep 2021
    Share Share
    OPKO Health Completes Enrollment in PII Trial of RAYALDEE for COVID-19 patients
    OPKO Health Completes Enrollment in PII Trial of RAYALDEE for COVID-19 patients

    30 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/30/2288690/0/en/OPKO-Health-Completes-Enrollment-in-Phase-2-Trial-Evaluating-RAYALDEE-as-a-Treatment-for-Symptomatic-COVID-19-Outpatients.html

    GLOBENEWSWIRE
    30 Aug 2021
    Share Share